Stockreport

Actuate Therapeutics to Ring the Nasdaq Opening Bell on Friday, August 23, 2024

Actuate Therapeutics, Inc. - Common stock  (ACTU) 
PDF CHICAGO and FORT WORTH, Texas, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceut [Read more]